|
MATR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.27589999968592E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.92830000037503E-07 |
| Normal-vs-Stage2 |
2.958300E-04 |
| Normal-vs-Stage3 |
7.423100E-03 |
| Normal-vs-Stage4 |
3.582600E-01 |
| Stage1-vs-Stage2 |
7.767000E-01 |
| Stage1-vs-Stage3 |
5.930000E-01 |
| Stage1-vs-Stage4 |
2.885200E-01 |
| Stage2-vs-Stage3 |
5.159200E-01 |
| Stage2-vs-Stage4 |
2.755000E-01 |
| Stage3-vs-Stage4 |
5.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45979999999213E-06 |
| Normal-vs-AfricanAmerican |
2.0835999999913E-05 |
| Normal-vs-Asian |
1.288400E-02 |
| Caucasian-vs-AfricanAmerican |
7.952000E-01 |
| Caucasian-vs-Asian |
9.144800E-01 |
| AfricanAmerican-vs-Asian |
9.830800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.93399999745847E-08 |
| Normal-vs-Female |
1.695540E-02 |
| Male-vs-Female |
6.363800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.567400E-04 |
| Normal-vs-Extreme_Weight |
1.00150000004184E-06 |
| Normal-vs-Obese |
4.761800E-04 |
| Normal-vs-Extreme_Obese |
1.036230E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.254000E-01 |
| Normal_Weight-vs-Obese |
3.335200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.021800E-01 |
| Extreme_Weight-vs-Obese |
1.629640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.623600E-01 |
| Obese-vs-Extreme_Obese |
2.108200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.507900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.980700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.11820000428631E-08 |
| Normal-vs-Age(81-100Yrs) |
2.29489999999943E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.035600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.423580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.122000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.621800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.438400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.08459999995192E-06 |
| Normal-VS-Type2 PRCC |
2.87919999997222E-06 |
| Normal-VS-KIRP CIMP |
3.756000E-03 |
| Normal-VS-Unclassified PRCC |
7.399600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.337800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.696000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.564000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.033400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.912800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.768800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14080000002126E-07 |
| Normal-vs-N1 |
4.747800E-01 |
| Normal-vs-N2 |
5.478500E-03 |
| N0-vs-N1 |
1.447840E-02 |
| N0-vs-N2 |
8.900200E-01 |
| N1-vs-N2 |
2.418600E-01 |
|
|
